当前位置: 首页 >> 检索结果
共有 3919 条符合本次的查询结果, 用时 2.2356618 秒

2621. Infections with herpes simplex viruses (1).

作者: L Corey.;P G Spear.
来源: N Engl J Med. 1986年314卷11期686-91页

2622. The pathogenesis of atherosclerosis--an update.

作者: R Ross.
来源: N Engl J Med. 1986年314卷8期488-500页

2623. Fatal asthma.

作者: S R Benatar.
来源: N Engl J Med. 1986年314卷7期423-9页

2624. Medical consequences of persistent viral infection.

作者: P Southern.;M B Oldstone.
来源: N Engl J Med. 1986年314卷6期359-67页

2625. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

作者: W S Colucci.;R F Wright.;E Braunwald.
来源: N Engl J Med. 1986年314卷6期349-58页

2626. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.

作者: W S Colucci.;R F Wright.;E Braunwald.
来源: N Engl J Med. 1986年314卷5期290-9页

2627. Cellular sodium transport in essential hypertension.

作者: P J Hilton.
来源: N Engl J Med. 1986年314卷4期222-9页

2628. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery.

作者: R F DeBusk.;C G Blomqvist.;N T Kouchoukos.;R V Luepker.;H S Miller.;A J Moss.;M L Pollock.;T J Reeves.;R H Selvester.;W B Stason.
来源: N Engl J Med. 1986年314卷3期161-6页

2629. Hemodynamically mediated acute renal failure.

作者: B D Myers.;S M Moran.
来源: N Engl J Med. 1986年314卷2期97-105页

2630. Osteosarcoma: fifteen years later.

作者: A M Goorin.;H T Abelson.;E Frei.
来源: N Engl J Med. 1985年313卷26期1637-43页

2631. The prospects for and pathways toward a vaccine for AIDS.

作者: D P Francis.;J C Petricciani.
来源: N Engl J Med. 1985年313卷25期1586-90页

2632. Surgery for hepatic neoplasms.

作者: R A Malt.
来源: N Engl J Med. 1985年313卷25期1591-6页

2633. Hepatitis in pregnancy.

作者: D R Snydman.
来源: N Engl J Med. 1985年313卷22期1398-401页

2635. Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections.

作者: S Stagno.;R J Whitley.
来源: N Engl J Med. 1985年313卷21期1327-30页

2636. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

作者: J H Laragh.
来源: N Engl J Med. 1985年313卷21期1330-40页
The renin-angiotensin-aldosterone axis exerts major control over sodium and potassium balance and arterial blood pressure. These three functions are continuously regulated by changes in angiotensin II and aldosterone levels in response to wide variations in dietary intake of sodium and potassium. In addition, changes in intrarenal physical factors cause changes in the supply of distal tubular sodium that, in turn, work to determine sodium and potassium excretion and to modulate the release of renal renin. However, certain aspects of sodium homeostasis cannot be fully explained either by the activity of the renin system or by intrarenal physical factors, and this has led investigators to search for other natriuretic hormonal mechanisms. Recently, it has become clear that atrial tissue contains a group of peptides, at least one of which is probably secreted as a regulatory hormone. In animals, these atrial peptides produce immediate, marked natriuresis associated with a rise in glomerular filtration rate (but no alteration of total renal flow) and a simultaneous decrease in arterial blood pressure. Atrial peptides also inhibit renal renin secretion and adrenal cortical secretion of aldosterone, and they oppose the vasoconstrictive action of angiotensin II. One of these atrial peptides may therefore be the long-sought natriuretic hormone, though in a different form and shape than was envisioned. The fact that atrial peptide works to oppose the renin system at four points suggests that this new hormone could have a major complementary role in long-term regulation of blood pressure and electrolyte homeostasis. In this construction the renin system primarily defends sodium balance and blood pressure, with the atrial hormone having an increasing counter-influence in situations involving high blood pressure or sodium surfeit. We can soon expect to learn more about this atrial hormone, including which peptide is the active circulating hormone, what induces or inhibits its release, and what part it plays in cardiovascular diseases.

2637. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections.

作者: S Stagno.;R J Whitley.
来源: N Engl J Med. 1985年313卷20期1270-4页

2638. Type A viral hepatitis. New developments in an old disease.

作者: S M Lemon.
来源: N Engl J Med. 1985年313卷17期1059-67页

2639. Pet-associated illness.

作者: D L Elliot.;S W Tolle.;L Goldberg.;J B Miller.
来源: N Engl J Med. 1985年313卷16期985-95页

2640. Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.

作者: S H Snyder.;I J Reynolds.
来源: N Engl J Med. 1985年313卷16期995-1002页
共有 3919 条符合本次的查询结果, 用时 2.2356618 秒